AIIMS To Finally Start COVAXIN Trials From Monday

The All India Institute of Medical Sciences, Delhi finally received approval from its ethical committee to participate in the human trials for Bharat Biotech's COVAXIN trials. Dr. Sanjay Rai, principal investigator for this trial at AIIMS told ANI that the institute will start enrolling individiuals for the trials from Monday, July 20. 

The trial was intended to begin from July 7 in all the eight participating medical colleges. The Indian Council of Medical Research (ICMR) received flak as it wrote to these colleges to complete their phase I/II trials by August 15.